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ABSTRACT
Introduction: Anecdotal reports suggest that high-risk
drinking in pregnancy is common in some remote
Australian communities. Alcohol is teratogenic and
may cause a range of lifelong conditions termed
‘fetal alcohol spectrum disorders’ (FASD). Australia
has few diagnostic services for FASD, and prevalence
of these neurodevelopmental disorders remains
unknown. In 2009, Aboriginal leaders in the
remote Fitzroy Valley in North Western Australia
identiﬁed FASD as a community priority and
initiated the Lililwan
i Project in partnership with
leading research organisations. This project will
establish the prevalence of FASD and other health
and developmental problems in school-aged
children residing in the Fitzroy Valley, providing data to
inform FASD prevention and management.
Methods and analysis: This is a population-based
active case ascertainment study of all children born in
2002 and 2003 and residing in the Fitzroy Valley.
Participants will be identiﬁed from the Fitzroy Valley
Population Project and Communicare databases.
Parents/carers will be interviewed using a standardised
diagnostic questionnaire modiﬁed for local
language and cultural requirements to determine the
demographics, antenatal exposures, birth outcomes,
education and psychosocial status of each
child. A comprehensive interdisciplinary health
and neurodevelopmental assessment will be
performed using tests and operational deﬁnitions
adapted for the local context. Internationally
recognised diagnostic criteria will be applied to
determine FASD prevalence. Relationships between
pregnancy exposures and early life trauma,
neurodevelopmental, health and education outcomes
will be evaluated using regression analysis. Results
will be reported according to STROBE guidelines for
observational studies.
Ethics and dissemination: Ethics approval has been
granted by the University of Sydney Human Research
Ethics Committee, the Western Australian Aboriginal
Health Information and Ethics Committee, the Western
Australian Country Health Service Board Research
Ethics Committee and the Kimberley Aboriginal Health
Planning Forum Research Sub-committee. Results will
ARTICLE SUMMARY
Article focus
- To establish the need for prevalence data on
FASD in remote Australia and for improved
awareness and diagnosis of FASD.
- To describe the protocol used in Australia’s ﬁrst
population-based study of FASD prevalence
using active case ascertainment in remote
Aboriginal communities.
- To demonstrate a process of community consul-
tation and clinical research that respects the
priorities, language and culture of Aboriginal
communities.
Key messages
- Accurate prevalence data on FASD and other
health and developmental outcomes will inform
prevention, service provision and policy in child
health, education and justice.
- This research will provide immediate and direct
beneﬁts to participants and the broader commu-
nity, including a feasible and transferable
model of FASD diagnosis and a model for
culturally responsive research with Aboriginal
communities.
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INTRODUCTION
The Fitzroy Valley is 2500 km North of Perth and 400 km
east of Broome, in the remote West Kimberley region of
Western Australia, with Fitzroy Crossing town at its
centre. The Valley is home to approximately 4500
people, 80% of whom are Aboriginal, belonging to ﬁve
language groups (Bunuba, Walmajarri/Wangkatjungka,
Nyikina and Gooniyandi). There are 45 distinct
communities ranging from larger communities (300
people) in the Fitzroy Crossing town site to small
Aboriginal cattle station communities with as few as
10e20 people depending on the season.
In 2007, these communities were in crisis with high
rates of alcohol abuse, alcohol-related harms, violence
and crime. During that year, there were 55 deaths (13
being suicides), with a coronial enquiry ﬁnding alcohol
to be a factor in many deaths (June Oscar, personal
communication, 2010). In the face of resistance from
those with a vested interest in the sale of alcohol, brave
local women led their community to successfully lobby
for restrictions on take-away sales of full strength
alcohol such that: the sale of packaged liquor, exceeding
a concentration of ethanol in liquor of 2.7% at 208C, is
prohibited to any person, other than a lodger (as deﬁned in
Section 3 of the Liquor Control Act 1988). The beneﬁts of
these restrictions for the community were both imme-
diate and enduring. One year after introducing the
restrictions, an independent evaluation showed a 28%
reduction in alcohol-related police tasks, a 36% reduc-
tion in alcohol-related presentations to hospital, a 14%
increase in school attendance and a reduction in the
sale of pure alcohol from the Crossing Inn from 104 l/
day to 23 l/day.
1 A new state of sobriety had emerged in
Fitzroy Crossing, and a number of remote satellite
communities in the Fitzroy Valley took steps to become
‘dry communities’, with complete alcohol bans. The
community became aware of a range of conditions
called fetal alcohol spectrum disorders or ‘FASD’ and
recognised the signs and symptoms in many children. In
2009, members of Nindilingarri Cultural Health
Services and Marninwarntikura Women’s Resource
Centre, in collaboration with community members,
health and education professionals, developed
a strategy to overcome FASD and early life trauma in the
Fitzroy Valley. They called the strategy Marulu. This is
a word from the Bunuba language meaning ‘precious,
worth nurturing’, which reﬂects how they feel about
children. The three priorities of the strategy are to
prevent FASD, diagnose FASD and support affected
families. Building on existing relationships, the
community invited The George Institute for Global
Health and the Sydney Medical School, University of
Sydney, to partner with them in the Lililwan Project to
enable FASD diagnosis and determine prevalence. Prior
to commencing this work, extensive community
consultation was undertaken to identify potential risks
and beneﬁts, resulting in well-informed and widespread
community support.
2
Fetal alcohol spectrum disorders
Alcohol is a teratogen and exposure in utero can cause
a spectrum of lifelong physical and neurocognitive
abnormalities termed ‘fetal alcohol spectrum disorders’
(FASD), including speciﬁc diagnoses of fetal alcohol
syndrome (FAS), partial fetal alcohol syndrome (pFAS)
and neurodevelopmental disorderealcohol exposed
(ND/AE).
3 The teratogenic effects of alcohol were
reported in the medical literature in 1968,
4 and the term
‘FAS’ was used in 1973 to describe a pattern of charac-
teristic facial features, growth deﬁciency and central
nervous system (CNS) impairment in babies exposed to
alcohol in utero.
5 There is increasing knowledge about
the effects of antenatal alcohol exposure on brain
structure
67and function, including memory, cognition,
executive function, gross and ﬁne motor control, sensory
processing, language and behaviour.
689Neuro-
developmental disabilities associated with FASD signiﬁ-
cantly impact quality of life, social and economic
participation. Families caring for affected individuals
report very high levels of caregiving stress, particularly if
the child has problems with executive functioning.
10
There is often an overlay of guilt that FASD could have
been prevented.
10 Individuals diagnosed with FASD
frequently develop secondary disabilities associated with
high rates of disrupted education (61%), including
mental health problems (90%), trouble with the law
(60%) and substance abuse (39%).
11 Compounding the
tragedy for individuals and families, service use and loss
of productivity for an individual with any diagnosis on
the FASD spectrum costs up to US$22000 per year.
12 For
people with FAS, the lifetime cost may reach US$2.5
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Strengths and limitations of this study
- The study was a response to a local community initiative and
followed extensive community consultation.
- The population-based active method of case ascertainment will
provide the most accurate prevalence data for diagnoses on the
entire FASD spectrum and other health and developmental
outcomes.
- Standardised and locally developed clinical assessments
whose interpretation is less biased by culture and language
have been chosen carefully with cross-cultural considerations
in mind and are considered valid for the purpose of the study.
- There are no normative data for Aboriginal children for the
assessments used in the study.
- Study ﬁndings may not generalise to all children born in the
Fitzroy Valley following the introduction of community-led
alcohol restrictions in 2007, after which time FASD prevalence
may have decreased.
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12 When welfare and justice costs are added, the
economic burden is more substantial. Prevalence data
on FASD are needed to document the extent of the
problem and inform prevention strategies and provision
of health, education and justice services.
Alcohol use in pregnancy
Australia has among the highest annual per capita
consumption of pure alcohol, at 10e12.49 l.
13 In Fitzroy
Crossing immediately prior to alcohol restrictions being
implemented in 2007, the annual per capita alcohol
consumption was estimated at 27 l (over three times the
national average) or 35 cans of beer per week for every
person in Fitzroy Crossing.
14
Alcohol use in pregnancy is common. Of pregnant
women in Moscow, 52% reported alcohol consumption
in the most recent month of their pregnancy.
15 In France,
52.2% of women surveyed drank at least once during
their pregnancy and 13% of those who drank consumed
ﬁve or more drinks per occasion in a ‘binge’ pattern.
16
Large studies in the USA show that approximately 12%e
13%
17 18 of women drink in pregnancy, one in 50 (2%) of
all women surveyed drinking in a ‘binge’ pattern during
pregnancy. Importantly, these international ﬁgures
may underestimate the problem: a limitation of surveying
women during pregnancy is under-reporting, whereas
in retrospective surveys, women report higher
consumption.
19
In Australia, alcohol consumption is common among
women of childbearing age. Of women aged
18e24 years, 11% drink at risky/high-risk levels on
a weekly basis.
20 National surveys show differences in
drinking patterns between Indigenous and non-Indige-
nous Australian women.
21 Indigenous women are less
likely to drink alcohol than non-Indigenous women, but
those who do drink are more likely to do so at hazardous
levels.
21 In a survey of almost 5000 non-Indigenous
Western Australian women between 1995 and 1997, 60%
reported drinking in pregnancy, and 4% reported
drinking at ‘binge’ levels of ﬁve or more standard drinks
per occasion during pregnancy.
22 In one large national
survey, 20% of Indigenous Australian women reported
drinking in pregnancy,
23 but population-based data,
particularly from remote settings, are scarce. Focus
group work with Indigenous women suggests that
reasons for drinking include lack of knowledge about
harms to the fetus, unemployment, having a partner who
drinks, domestic violence, loss of traditional land and
culture and the legacy of the ‘stolen generation’ when
children were forcibly removed from their mothers by
government authorities between 1909 and 1969
(Heather D’Antoine, personal communication, 2011).
FASD prevalence
International estimates of prevalence of FASD vary
markedly depending on study methods. Surveillance or
record review studies report a lower prevalence (often
due to under-reporting) than clinic-based studies (in
which there may be selection bias), while active case
ascertainment studies report the highest prevalence.
24
Most studies report only FAS or partial FAS because the
presence of physical signs makes these conditions easier
to identify than ND/AE, in which dysmorphology may
be subtle or absent.
24 25 The effect of study method on
reported prevalence is evident from a review of FAS
prevalence studies to 2009. Passive surveillance and
clinic-based studies report a median prevalence of 0.27
and 1.9 cases per 1000 people, respectively, while active
case ascertainment studies report a median of 8.5 cases
per 1000 people.
24 The demographics of the study
population and inclusion of the entire FASD spectrum
also inﬂuences prevalence rates. The few active case
ascertainment studies that included all diagnoses on the
FASD spectrum report a median prevalence of 19.0 cases
per 1000 people.
24 These ﬁndings suggest that active
case ascertainment studies are likely to be most accurate
and that assessing the full range of diagnoses on the
FASD spectrum in an entire population in high-risk
communities is likely to result in high prevalence ﬁgures.
In Australia, the prevalence of FASD is unknown, and
there are few FASD screening programmes or diagnostic
clinics.
26 27 Under-ascertainment is likely due to lack of
screening of children at risk and under-diagnosis of
FASD.
28 In Western Australia, fewer than 50% of health
professionals routinely ask about alcohol use during
pregnancy and only 12% know the four diagnostic
features of FAS.
29 30 Australian researchers have
attempted to estimate the prevalence of FAS or FASD. In
Western Australia, FAS prevalence was reported as 0.18
cases per 1000 West Australian live births between 1980
and 1997 (with rates 100 times higher in the Indigenous
population).
31 In an audit of the Victorian Birth Defects
Register, the prevalence of FAS was between 0.01 and
0.03 cases per 1000 live births in Victoria between 1995
and 2002.
32 A retrospective medical record and paedi-
atric letter review of children born between 1990 and
2000 in Darwin, Northern Territory, estimated the
overall prevalence of FAS to be 0.68 per 1000 children
seen in the Royal Darwin Hospital during the study
period (and 1.87 per 1000 Indigenous children).
33
An active surveillance study involved paediatricians
notifying newly diagnosed (incident) cases of FAS to the
Australian Paediatric Surveillance Unit each month
between 2001 and 2004. A prevalence of 0.06 per 1000
live births over the study period was found.
34 Signiﬁ-
cantly higher birth prevalence and incidence rates
were reported in the Indigenous population.
34 Limita-
tions of Australian studies include likely under-diagnosis
and under-reporting, limited data on prenatal alcohol
exposure, variable data on which diagnoses were
made, inconsistent use of diagnostic criteria and limited
access to remote populations and therefore under-
representation of this high-risk group.
Although attempts to ascertain FASD prevalence in
Australia have been made, there is a need for a rigorous
population-based active case ascertainment study with
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diagnostic criteria for the entire spectrum of FASD
diagnoses.
Evidence gaps and the signiﬁcance of this work
Accurate FASD prevalence data are needed to plan
prevention, diagnostic and management strategies.
35
Accurate data on fetal alcohol exposure is essential to
make a FASD diagnosis and examine the relationship
between quantity and timing of exposure, and physical
and neurocognitive outcomes. Diagnosing all conditions
on the FASD spectrum (FAS, pFAS, ND/AE) is impor-
tant because signiﬁcant learning and behavioural prob-
lems, such as problems in memory and in higher level
cognitive and language skills, can result from antenatal
alcohol exposure in the absence of characteristic facial
features and growth restriction seen in FAS.
36 In high-
risk communities, particularly where retention of tradi-
tional culture relies on stories and songs passed on
orally, there is an urgency to address the devastating
effects of FASD and to determine the most effective
prevention strategies.
37 38 Clinical studies with active
case ascertainment will provide the highest and most
accurate rates of FASD prevalence.
24
In Australia, addressing FASD has become a focus of
the Prime Minister’s Science, Engineering and Innova-
tion Council and the Australian Human Rights
Commission and a Parliamentary Inquiry into the
prevention, incidence and management of FASD is
currently underway.
37 39 40
Study aims
The aims of the Lililwan Project are as follows:
< Establish the prevalence of FASD and other health
and developmental problems in all children born in
2002 and 2003 and residing in the Fitzroy Valley.
< Determine relationships between pregnancy
exposures and neurodevelopmental outcomes.
Additionally, the researchers undertake to provide
individual, multidisciplinary health management plans
for each participant and to deliver education and family
support to increase the beneﬁt of the study to partici-
pants and their communities. Data will also be used in
service planning and prevention programmes.
Hypotheses
It is hypothesised that:
< Using validated and locally developed measures, we
will identify higher prevalence rates of FASD, devel-
opmental delay, behavioural problems, hearing impair-
ment and educational underachievement in this
population than predicted by current Australian data.
< We will identify modiﬁable risk factors for adverse
health and educational outcomes.
METHODS AND ANALYSIS
Study design
The Lililwan Project is a population-based active case
ascertainment study of the prevalence of FASD.
Setting
This study will take place in the remote Fitzroy Valley of
North Western Australia, including Fitzroy Crossing
town and approximately 45 remote communities repre-
senting the language groups of the Bunuba, Walmajarri/
Wangkatjungka, Gooniyandi and Nyikina peoples.
41 The
Fitzroy Valley is approximately 2500 km North of Perth
and 400 km East of Broome and includes communities
within a radius of 200 km from Fitzroy Crossing town.
The total population of the Fitzroy Valley is 4500,
approximately 80% being Aboriginal.
41
Study timeline
The project is being carried out between October 2009
and June 2014 in two stages. Stage 1 includes community
consultation, recruitment and interviews with parents/
carers using a diagnostic questionnaire and will occur
between 2009 and 2011. Stage 2 involves interdisci-
plinary clinical assessments, diagnostic case conferences
and feedback of management plans to participants and
health and education providers and will occur during
2011 and 2012. Data entry and analysis, preparation of
reports and publication of manuscripts will occur
between 2012 and 2014.
Participants
Participants will be all children born between 1 January
2002 and 31 December 2003 and living in the Fitzroy
Valley in 2010 or 2011. They will be identiﬁed from the
Fitzroy Valley Population Project
41 and Communicare
(electronic population health program) databases. This
age group was selected as being sufﬁciently old to
participate in assessment for FASD and health, educa-
tional and behavioural outcomes, yet young enough to
beneﬁt from recommended interventions in the health,
school and home settings. These children will likely have
environmental and alcohol exposures similar to those
living in remote communities elsewhere in Western
Australia, the Northern Territory, South Australia,
Queensland, Victoria and New South Wales. Findings
may also be relevant to remote or low socioeconomic
communities internationally.
Recruitment
Parents or carers of children in the cohort will be visited
by ‘community navigators’ (local Aboriginal people
working on the research team) who will explain the
purpose of the study using participant information
statements and consent forms, read to parents/carers in
plain English, Kimberley Kriol or in one of the local
Aboriginal languages as required. Pictorial aides have
been developed to assist with explanation of the study
rationale, methods and clinical assessment processes.
With assistance from local community navigators,
researchers will obtain written consent for participation
in the study at three points in time: for parent/carer
participation in stage 1 interviews using a diagnostic
questionnaire, prior to interdisciplinary clinical
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plans with health and education providers, and making
relevant referrals.
Due to inconsistent recording in the remote setting,
participants’ birth dates will be documented using
multiple sources: midwife birth notiﬁcation forms, hard
copy medical records and Communicare electronic
health records. Birth dates will be conﬁrmed with
parents/carers for accuracy. Families are very mobile
within the Fitzroy Valley and often leave the Valley for
climatic, cultural or personal reasons.
41 Participants will
be located using community navigator advice on their
current location.
Diagnostic criteria, outcome measures and statistical
analysis
Analyses will be carried out in the context of the study
aims and hypotheses described above. The Canadian
guidelines for the diagnosis of FASD
42 will be used to
assign speciﬁc diagnoses along the FASD spectrum based
on comprehensive interdisciplinary clinical assessment.
Diagnostic criteria are listed at table 1.
The Canadian guidelines were chosen following feed-
back from local health professionals and cultural leaders
regarding the diagnostic terminology and practicability
of use in a remote clinical setting. Due to the unique
cultural and language context of the study population,
speciﬁc clinical assessments whose interpretation is less
biased by culture and language were chosen.
Prevalence of FASD (including diagnoses of FAS,
partial FAS and ND/AE), and other health and selected
developmental diagnoses, will be calculated as the
proportion of children diagnosed in the total population
of children in the age group and expressed per 1000.
Prevalence will be reported in all children in two age
groups (those born in 2002 and 2003); hence, CIs will
not be calculated.
In children diagnosed with FASD, associations
between their diagnosis and education and health
outcomes will be examined. In children exposed to
alcohol in utero associations between all pregnancy
exposures (including alcohol and other adverse ante-
natal events) and early life trauma (including household
overcrowding, emotional or physical trauma), and
health and developmental outcomes (including speech
and language, visual motor integration, cognition and
executive function) will be examined.
Descriptive analyses will be conducted to obtain
f r e q u e n c i e sa n dm e a n sf o rv a r i a b l e so fi n t e r e s t ,
followed by univariate analyses to assess whether expo-
sures are signiﬁcantly related to outcomes and to
inform multivariate analyses. Multivariate models will
then be built if appropriate, with inclusion of other
variables as potential confounders. Logistic regression
models will be built for binary outcome variables and
linear models for continuous outcome variables.
Potential confounders will be selected for inclusion in
regression models based on the published literature or
if the variable is signiﬁcantly correlated with the
outcome and is a main risk factor in the univariate
analysis (p<0.2).
When statistical power allows, plausible effect modiﬁ-
cation will be tested by adding an interaction term to the
full model containing all possible confounders. If effect
modiﬁcation is found (a signiﬁcant interaction variable
p<0.05), further analyses will be stratiﬁed by that
variable.
All analyses will be conducted using SAS V.9.2. Results
will be reported according to STROBE guidelines for
reporting observational studies.
44
Normative population data are not available for
Australian Aboriginal children for any of the clinical
assessments used in the study. Clinicians have consulted
extensively to choose assessments that minimise cultural
and linguistic bias. Population norms for facial features
of FAS are available for Caucasian and Africane
American populations. The AfricaneAmerican Lip-
Philtrum Guide
45 will be used for assessing lip thinness
and philtrum smoothness in Aboriginal children, and
the Hall population reference data will be used for
palpebral ﬁssure length.
43 For growth parameters, WHO
charts will be used, as they are most relevant to this
population.
Data collection
Data will be collected in two stages.
Stage 1: Characterising the cohort by administration
of a diagnostic questionnaire and medical note review
A comprehensive diagnostic questionnaire has been
developed for use in interviews with parents/carers.
Content is based on a literature review of FASD diag-
nostic criteria and existing diagnostic checklists
42 45e49
with consideration of potential antenatal and environ-
mental inﬂuences on child development,
50e53 maternal
risk factors for birth defects and risk factors for
FASD.
54e57
The diagnostic questionnaire includes 114 questions
about child demographics, schooling, language, place of
residence and living conditions, prenatal exposures
(including alcohol quantiﬁed using the AUDIT-C
58),
neonatal history, early life trauma (relevant to some
remote Aboriginal communities), health and educa-
tional outcomes and family characteristics. It was devel-
oped by paediatricians in plain English and modiﬁed by
local language experts at the Kimberley Interpreting
Service to ensure content and language appropriateness.
Reliability testing was conducted on a pilot question-
naire, which was then revised before formal reliability
testing, which conﬁrmed high inter- and intra-rater
reliability. Community navigators will assist researchers
to administer the questionnaire in plain English,
Kimberley Kriol or local Aboriginal languages as
required (Bunuba, Walmajarri/Wangkatjungka,
Gooniyandi and Nyikina). Participant medical records
will be comprehensively reviewed for information
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developmental outcomes documented at the time of
review. Hard copy medical records, Communicare
community health records and midwife notiﬁcation data
will be reviewed.
Stage 2: Comprehensive interdisciplinary clinical assessments
A trial of sage 2 interdisciplinary health and neuro-
developmental assessments will be conducted in Fitzroy
Crossing for six children to pilot clinical assessment
measures and processes. After the pilot phase, direct
testing of each child will be conducted over three non-
consecutive days (with additional data gathered from
teachers and parents through questionnaire when
relevant). This is detailed in table 2.
Day 1 assessments (including audiology and ophthal-
mology) will be conducted over a 2-week period
(between 1 week and 5 months before the day 2 and 3
clinical assessments). Information from teachers will be
requested prior to day 2 and 3 assessments; however, for
logistical reasons, this information may not be immedi-
ately available. Day 2 and 3 assessments will not always be
conducted in the same order for logistical reasons.
Interdisciplinary case conferencing will be used to assign
speciﬁc diagnoses of FASD (including FAS, pFAS and
ND/AE) and other health and developmental problems.
Table 1 Diagnostic criteria based on the Canadian guidelines for the diagnosis of fetal alcohol spectrum disorders
42
Diagnostic category Fetal alcohol syndrome
Partial fetal alcohol
syndrome
Neurodevelopmental
disorderealcohol exposed
Diagnostic criteria Requires all four criteria
below to be met
Requires conﬁrmed prenatal
alcohol exposure, the
presence of two of the three
characteristic facial anomalies
at any age and CNS criteria to
be met
Requires conﬁrmed prenatal
alcohol exposure and CNS
criteria to be met
Prenatal alcohol
exposure
Conﬁrmed or unknown Conﬁrmed Conﬁrmed
Facial anomalies Presence of all three of the
following facial anomalies at
any age:
< Short palpebral ﬁssure
length (#2 SDs below the
mean using the Hall
charts
43)
< Smooth philtrum (rank 4 or
5 on the UW Lip-Philtrum
Guide*)
< Thin upper lip (rank 4 or 5
on the UW Lip-Philtrum
Guide)
Presence of any two of the
following facial anomalies at
any age:
< Short palpebral ﬁssure
length (#2 SDs below the
mean)
< Smooth philtrum (rank 4 or
5 on the UW Lip-Philtrum
Guide)
< Thin upper lip (rank 4 or 5
on the UW Lip-Philtrum
Guide)
No anomalies required
Growth deﬁcit Prenatal or postnatal growth
deﬁcit indicated by birth length
or weight #10th percentile
adjusted for gestational age or
postnatal height or weight
#10th percentile
No deﬁcit required No deﬁcit required
Central nervous
system (CNS)
abnormality
Signiﬁcant CNS dysfunction (evidence of impairment in three or more of the following
CNS domains):
< Hard and soft neurological signs; seizure disorder; gross and ﬁne motor functioning;
articulation, phonology and motor speech
< Cognition (IQ or uneven cognitive proﬁle)
< Memory
< Executive functioning and abstract reasoning
< Communication (expressive and receptive language)
< Attention deﬁcit/hyperactivity +/  other behavioural problems; abnormal sensory processing
< Visual motor integration
< Adaptive behaviour/social skills/social communication
< Academic achievement
< CNS structure (including head circumference #3rd percentile or other structural
CNS abnormality)
*The University of Washington (UW) Lip-Philtrum Guide is a 5-point Likert scale with representative photographs of lip and philtrum
combinations with ranks 1e3 within normal limits and ranks 4 and 5 outside normal limits.
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Discipline Assessment Outcome measures
Day 1*
Community navigator Cultural/language/spiritual
health/social assessmenty
Impact of cultural and social determinants
on child health and ability to participate in
the Lililwan Project
Audiology Tympanometry Tympanic membrane mobility/middle ear
function
Audiometry Conductive and sensorineural
hearing loss
Video-otoscopy Tympanic membrane integrity
or abnormality
LiSN-S assessment for
Central Auditory Processing
Disorder
59
Auditory processing abilities
Ophthalmology Culturally appropriate optotypes Visual acuity
Nidek Autorefractor Refractive status
Clinical eye examination Ocular mobility, strabismus, nystagmus
Colour photograph of front of
the eye
Structure of the iris and cornea
Colour photograph of the retina
and optic nerve
Optic nerve size, retinal vascular status
School teacher ASEBA teacher report form
60 Educational, competence and behavioural
proﬁle from teacher perspective
Sensory proﬁle: school
companion
61
Sensory processing proﬁle in the school
setting
Speech/language qualitative
questionnaire
Speech, language and literacy abilities in
the school setting
Child health nurse Anthropometric measurements Height, weight, body mass index, head
circumference, abdominal circumference,
mid-arm circumference
Day 2z
Child psychology Universal Non-verbal Intelligence
Test
62
Cognitive proﬁle, using non-verbal
assessment of memory and reasoning, in
symbolic and non-symbolic modalities
ASEBA child behaviour
checklist/6e18
60 (carer
questionnaire)x
Competence in school, activities and
social skills and behavioural problems
proﬁle, from carer perspective
Children’s colour trails
63 Aspects of executive function
Digit span subtest of the Wechsler
Intelligence Scale for Children-IV
64
Aspects of executive function and short-
term auditory memory
Occupational therapy Bruininks-Oseretsky Test of Motor
Proﬁciencydage 4e21 years
(BOT2)
65
Fine motor precision, ﬁne motor
integration, manual dexterity and overall
manual coordination
Buktenica Test of Visual-Motor
Integrationdage 2e100 years,
with Visual Perception and Motor
Coordination subtests
66
Visual motor skill, perception and
integration
Short sensory proﬁle (carer
questionnaire)
67 x
Sensory processing in the home setting
Continued
Fitzpatrick JP, Elliott EJ, Latimer J, et al. BMJ Open 2012;2:e000968. doi:10.1136/bmjopen-2012-000968 7
The Lililwan Project study protocol: FASD prevalence in Australian Aboriginal communitiesFASD diagnoses will be based on categorisation of
dysmorphology, growth restriction, alcohol exposure,
CNS structure and domains of neurodevelopmental
impairment as outlined in table 1. To avoid bias, clini-
cians will be blinded to alcohol exposure until after they
have scored and determined outcomes for facial
anomalies, growth deﬁcit and CNS abnormalities.
Communicating results to participants and local service
providers
A composite interdisciplinary report and management
plan will be compiled during the interdisciplinary case
conference. The assessment ﬁndings will be communi-
cated to parents and carers (with the assistance of
a community navigator if appropriate) and, with
parental consent, information about individual children
will be provided to relevant teachers and health
professionals.
Professional development sessions will be carried out
in the schools of all participating communities. When
a diagnosis on the FASD spectrum is made, follow-up
information and support will be provided to families by
an experienced educator and psychologist employed
through Marninwarntikura Women’s Resource Centre.
Strategic planning by community leaders for ongoing
support and services will occur as appropriate as part of
the broader FASD strategy.
Ethics and dissemination
This study of child health in a predominately Aboriginal
population requires particular consideration of cultural
and language issues. Ethics approval has been granted
for all stages of this study (stage 1 administration of
diagnostic questionnaires, a trial of stage 2 clinical
assessments and stage 2 clinical assessments) by the
University of Sydney Human Research Ethics Committee
(approval numbers 12527, 13187, 13551), the Western
Australian Aboriginal Health Information and Ethics
Committee (approval numbers 271-01/10, 319-10/10,
344-04/11), the Western Australian Country Health
Service Board Research Ethics Committee (approval
numbers 2010:01, 2010:28, 2011:04) and the Kimberley
Table 2 Continued
Discipline Assessment Outcome measures
Day 3z
Speech and language: screening
assessments developed locally for
Kimberley Kriol speakers speciﬁcally
for this project, based on
consultation with clinicians and
language consultants and review
of literature including Gould
68
Video recording of children
participating in free play/activity
for 10e15 min
Social communication and peer
interaction skills
Interactive story telling using a
culturally familiar story with moral
theme (conducted in Kimberley Kriol)
Scores of comprehension using Blank
Levels of questioning, expressive
language and degree of prompting
required (eg, repetition/rephrasing of
question)
Non-word repetition task Working phonological memory, literacy
skills and phonological awareness
Sequencing and narrative discourse
activity (conducted in Kimberley Kriol)
Sequencing, grammar, recount, higher
level expressive language
Oromotor assessment Articulation, phonology and motor speech
function
Validated screening test used
in English-speaking children
Clinical Evaluation of Language
Fundamentals Screening Test
(CELF 4), Australian language
adaptationdage 5e21 years
69
Screening test for risk of a language
disorder
Paediatrics Complete physical, neurological and
dysmorphology examination (including
palpebral ﬁssure length measurement
and use of UW Lip-Philtrum Guide
45)
Identiﬁcation of dysmorphologies speciﬁc
to antenatal alcohol exposure and
physical health status (including common
dental, skin, ear and respiratory disease)
Interpretation of anthropometric data
using WHO child growth standards
70
Evidence of growth restriction,
microcephaly
Physiotherapy Bruininks-Oseretsky Test of Motor
Proﬁciencydage 4e21 years (BOT2)
65
Bilateral coordination, balance, running
speed and agility, upper limb coordination,
overall body coordination, strength and
agility
Quick Neurological Screening TestdII
(Revised edition)dage 5 and above
71
Soft neurological signs
*Day 1 assessments will occur over a 2-week period for the entire cohort, not consecutively with day 2 or 3 assessments.
yCommunity navigators will conduct an informal non-standardised assessment of cultural, language and social issues and relay any relevant
information to the clinical team for consideration prior to assessment and at the time of case conferencing.
zFor logistical reasons, day 2 and 3 assessments will not always occur on consecutive days or in the order presented here.
xThe ASEBA Child Behaviour Questionnaire and Short Sensory Proﬁle (carer questionnaire) will be interpreted in the local language and some
items altered for cultural congruence.
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committee (approval numbers 2010-001, 2010-001, 2010-
001). A memorandum of understanding that clearly
deﬁned the project’s underlying principles, scope of
work, and roles and responsibilities of each organisation
was signed between Fitzroy Valley community organisa-
tions (Marninwarntikura Women’s Resource Centre,
Nindilingarri Cultural Health Services) and research
organisations (The George Institute, Sydney Medical
School).
Dissemination of the results of this study will occur on
numerous levels. Locally, individual health summaries and
management plans will be explained and provided to the
child’s parent/carer and with their consent to schools and
the local health service. Group results of prevalence
and other key ﬁndings will be shared with participant
communities during a series of community feedback
meetings. Manuscripts based on this work will be
submitted to leading journals in the ﬁeld and results will
be presented at scientiﬁc meetings in Australia and
internationally. Australian government agencies and
policy makers have been engaged through the study
group’s presentation to a Parliamentary Inquiry into FASD
incidence and prevention. The impact of study results at
a national level will be enhanced through the research
team’s strong links with the Australian Human Rights
Commission, who proﬁled the community’s strategy to
overcome FASD in the 2010 Social Justice Report.
37
DISCUSSION
A key strength of this study is that it resulted from a local
community initiative and followed extensive community
consultation. The population-based active method of
case ascertainment will provide accurate prevalence data
for diagnoses on the entire FASD spectrum and other
health and developmental outcomes. Relationships
between modiﬁable exposures and outcomes will inform
prevention, service provision and policy for child devel-
opment, healthcare, education and justice. Ethical,
language and cultural issues were paramount at all stages
of study conception and design. Local community
leaders are represented as Chief Investigators on the
study and approximately 30% of the research team are
local Aboriginal people. The language used to gain
consent for participation and during the study will be
informed and often delivered by local language experts.
Comprehensive assessment results will feed into inter-
disciplinary health summaries and management plans
that can be used by families, health and education
services to improve outcomes for these children in
a timely fashion.
Limitations of the clinical assessments include lack of
normative data for Aboriginal children. To mitigate this,
assessments were chosen carefully with cross-cultural
considerations in mind and are considered valid for the
purpose of this study. Additionally there are no norma-
tive data for Australian Aboriginals for the facial features
of FAS, so existing data from AfricaneAmerican popu-
lations will be used. Study ﬁndings may not generalise to
children born in the Fitzroy Valley following the intro-
duction of community-led alcohol restrictions in 2007,
after which time FASD prevalence may have decreased.
This work will provide accurate data on the health and
developmental status of an entire population of children
living in the Fitzroy Valley. Accurate estimation of the
prevalence of diagnoses on the FASD spectrum will
inform the level of health, education and other services
required in this population. Prevention strategies will be
based on detailed knowledge of antenatal exposures
and environmental impacts on child health and
development.
The Lililwan Project provides a model for effective
community consultation, adaptation of clinical and
research techniques to suit complex cultural and
language conditions and provision of short- and long-
term beneﬁt to communities that participate in clinical
research. Australia’s Social Justice Commissioner
described this project as ‘an example of researchers
reciprocating both the spirit and intent of the commu-
nity by working to address the challenges of FASD in
genuine partnershipdone where research is done with
the community and not just about the community’,
2
adding that ‘a process guided by a relationship under-
pinned by meaningful, respectful engagement and
collaboration will always be more effective and successful
than one that is not’.
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